Long-term follow-up of clofazimine (Lamprene) in the management of reactive phases of leprosy.
D002986:Clinical Trials as Topic; D002991:Clofazimine / Q000009:adverse effects / Q000627:therapeutic use*; D003622:Dapsone / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007918:Leprosy / Q000150:complications / Q000188:drug therapy*; D011247:Pregnancy
D003622:Dapsone; D002991:Clofazimine